Evidence map›Paper›PMID 11202236›Full record

ArticleJournal of clinical immunology2000

Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.

C Amiel, J P Kusnierz, Y Mouton, G Rook, J Stanford, M Singh, A Capron, G M Bahr

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

C AmielLaboratory of Molecular Immunology of Infections and Inflammation, Institut Pasteur de Lille, France.
J P Kusnierz
Y Mouton
G Rook
J Stanford
M Singh
A Capron
G M Bahr
Institut Pasteur de Lille · FRUniversity College London · GBCentre Hospitalier de Tourcoing · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunologic parameters, known to be grossly abnormal in HIV-1-infected subjects, were analyzed in 22 patients with sustained viral load suppression (<200 copies/ml) following long-term highly active antiretroviral therapy (HAART). Responses were compared with those from 18 HIV-seronegative healthy controls. Persistent phenotypic alterations in patients' blood mononuclear cells were minimal, though the percentages of lymphocytes that could be activated to produce interleukin-2 (IL-2) remained severely depressed. Using lymphoproliferative assays, a striking deficit in the capacity of patients to respond to the common mycobacterial antigens and particularly to recombinant heat-shock proteins paralleled the absence of responses to virus p24 antigen. In view of the important immunoregulatory role of stress proteins, these findings reveal profound functional deficiencies and persistent immune dysregulation in HIV-1 patients, despite successful HAART and a considerable recovery of CD4+ lymphocyte numbers. Rational immunotherapeutic approaches should be aimed to correct the characterized immune abnormalities.

Indexed as

Bacterial ProteinsLymphocyte ActivationAntigens, BacterialAntiretroviral Therapy, Highly ActiveCD4-Positive T-LymphocytesChaperonin 60ChaperoninsColorCytokinesFlow CytometryHIV-1HIV SeropositivityHSP70 Heat-Shock ProteinsHumansInterleukin-2Lymphocyte SubsetsAntigens, BacterialBacterial ProteinsChaperonin 60ChaperoninsCytokinesheat-shock protein 65, MycobacteriumHSP70 Heat-Shock ProteinsInterleukin-2Receptors, Immunologic

Identifiers

PMID11202236
OpenAlexW325352517

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.